Fujifilm Launches VXR Veterinary X-Ray Room, a Digital Radiography System Dedicated to Veterinary Imaging

All-in-one digital X-ray solution designed to streamline veterinarian’s workflow, while providing pets and their owners’ good health and peace of mind.

Lexington, Mass. –February 10, 2021 – FUJIFILM Medical Systems U.S.A., Inc., a leading provider of diagnostic imaging and medical informatics solutions, and part of the greater Fujifilm Healthcare portfolio, is proud to introduce its first complete VXR Veterinary X-Ray Room. The innovative design of this new X-ray room is targeted for veterinarians who want to transition to high quality, low-dose X-rays with an affordable, versatile, easy to use, and easy to install system.

Advanced imaging modalities, including digital radiography and X-ray rooms, are quickly gaining popularity in veterinary medicine to help assist with injury, disease prevention, and detection. In fact, the veterinary imaging market is expected to reach $2.2 billion by 2025, more than a 35% increase compared against 2020.

“Fujifilm is committed to providing veterinary facilities with the affordable digital radiography technologies they need to advance diagnostic efficiency for our nation’s pets,” said Rick Banner, Senior Director of Marketing, Modality Solutions, FUJIFILM Medical Systems U.S.A., Inc. “With a focus on productivity and dose efficiency, our VXR Veterinary X-Ray Room is a robust X-ray suite that’s engineered to help providers accurately detect ailments and set new standards in veterinary care.”

Designed to contribute to a safe work environment for both clinicians and patients with low-dose, high sensitivity DR detectors and advanced image processing technologies, the VXR Veterinary X-ray room’s FDR ES detectors leverage Fujifilm’s patented Irradiation Side Sampling (ISS) technology and Dynamic Visualization(™) processing for high quality images that help assist in visualizing fine details with gentle dose. The VXR Veterinary X-ray room features a rotating Bucky that speeds workflow while reducing handling by allowing its 14×17” GOS or CsI detector to easily reposition for portrait and landscape images. Technicians can stay focused and close to patients through quicker exams with the system’s on-board FDX Console PLUS workstation that’s swivel-mounted at eye level and automatically sets the dose technique based on exam selection, further reducing workflow steps.

 “Dose, image quality, and ergonomics are of great importance in the veterinary space” said Jackie Mesa, Manager, Sales Support, FUJIFILM Medical Systems U.S.A., Inc. “Vets, techs, and pets sometimes deal with anesthesia, or have no choice but to be near the patient during exposure. We want them to be able to get the exam done quickly, easily, and get the best possible image at the lowest possible dose, every time. We thrilled to introduce a solution that does that.”

Just like in medical environments, veterinary staff and pets deserve the best in medical imaging, from patient experience, to tech workflow, to safety and image quality. The launch of the VXR Veterinary X-Ray Room is just one more example of Fujifilm’s continuous commitment to innovating for a healthier world for all patients.

For more information on the VXR Veterinary X-Ray Room, visit: https://stage.healthcaresolutions-us.fujifilm.com/products/diagnostic-imaging/veterinary/vxr-veterinary-x-ray-room

About Fujifilm

FUJIFILM Medical Systems U.S.A., Inc. is a leading provider of innovative diagnostic imaging products and medical informatics solutions that meet and exceed the evolving needs of healthcare facilities today and into the future. It’s ever expanding medical imaging solutions span digital radiography (DR), detectors, portables and suites, mammography systems with digital breast tomosynthesis, computed tomography solutions for oncology and radiology applications, technologically advanced flexible and surgical endoscopy and fluoroscopy solutions. Fujifilm enables interoperability through its Systems Integration offering as well as its comprehensive, AI-supported Synapse® Enterprise Imaging portfolio, which includes the TeraMedica Division of Fujifilm. Fujifilm’s in vitro diagnostics (IVD) portfolio includes clinical lab reagents, and biomarkers to assess the risk for the development of hepatocellular carcinoma in patients with chronic liver disease. FUJIFILM Medical Systems U.S.A., Inc. is headquartered in Lexington, Massachusetts. For more information please visit healthcaresolutions-us.fujifilm.com.  

FUJIFILM Holdings Corporation, Tokyo, Japan, brings cutting edge solutions to a broad range of global industries by leveraging its depth of knowledge and fundamental technologies developed in its relentless pursuit of innovation. Its proprietary core technologies contribute to the various fields including healthcare, graphic systems, highly functional materials, optical devices, digital imaging and document products. These products and services are based on its extensive portfolio of chemical, mechanical, optical, electronic and imaging technologies. For the year ended March 31, 2020, the company had global revenues of $22.1 billion, at an exchange rate of 109 yen to the dollar. Fujifilm is committed to responsible environmental stewardship and good corporate citizenship. For more information, please visit: www.fujifilmholdings.com.

Previous Press Release Fujifilm Announces New Colonoscope Technology Designed To Aid Visualization and Control during Colonoscopy Next Press Release Fujifilm Presents Award-winning Synapse Enterprise Imaging Portfolio at HIMSS 2022